New pill aims to control leukemia when other drugs fail
Disease control
Recruiting now
This study tests a new daily pill, TERN-701, for people with chronic myeloid leukemia (CML) whose current treatments are not working well or cause side effects. About 180 adults will take the pill once a day to see if it is safe and can control their cancer. The goal is to find t…
Phase: PHASE1, PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC